NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
44 hedge funds and large institutions have $44.5M invested in InVivo Therapeutics Holdings Corp in 2016 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 3 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
11% less capital invested
Capital invested by funds: $49.8M → $44.5M (-$5.39M)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
Holders
44
Holding in Top 10
1
Calls
$1.57M
Puts
$494K
Top Buyers
| 1 | +$432K | |
| 2 | +$429K | |
| 3 | +$331K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$330K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$241K |
Top Sellers
| 1 | -$255K | |
| 2 | -$231K | |
| 3 | -$221K | |
| 4 |
Citigroup
New York
|
-$188K |
| 5 |
SG Americas Securities
New York
|
-$143K |